Biocompatible Polymers and the Role of PDMS in BioMEMS

keyword Biocompatible polymers are polymers engineered to contact biological systems (cells, tissues, blood, or bodily fluids) without causing an unacceptable adverse host response. Importantly, biocompatibility is not “inertness”: it is a context-dependent relationship between material, biological system, and intended use (e.g., duration, tissue type, and exposure route).

In practice, “biocompatibility” for medical/biomedical devices is evaluated using standardized testing frameworks such as the ISO 10993 series (including specific guidance for biological evaluation and categories like blood compatibility/hemocompatibility). This matters for polymer selection because polymers may fail not due to bulk toxicity, but due to surface or interfacial effects (protein adsorption, platelet activation), chemical degradation, or leaching of low-molecular-weight species.

Key material-level requirements for biocompatible polymers

For BioMEMS, which often combines microfluidics, sensors, and cell culture, the polymer must satisfy mechanical, chemical, and interfacial constraints simultaneously:

keyword Ability of a material to perform with an appropriate host response in intended use context.
keyword Compatibility of a material with blood to avoid harmful blood responses.
keyword International standards series for biological evaluation of medical devices.

Properties that determine whether a polymer is suitable for BioMEMS

Biocompatible polymers used in BioMEMS are typically judged across five property families: mechanical integrity, chemical stability/low degradation, transport behavior, optical/electrical behavior (as relevant), and—critically—surface/interface behavior with biological media.

1) Mechanical properties and structural reliability

BioMEMS often use soft lithography and elastomeric membranes. Polymers must withstand handling and operating conditions (pressure, shear, repeated deformation for microvalves/actuators). PDMS is widely used because it combines elastomeric mechanical properties with fabrication ease for micro/nanostructures.

2) Chemical stability, curing completeness, and leaching

A frequent failure mode in polymer-on-chip systems is the presence of uncrosslinked or low-molecular-weight oligomers that can diffuse out when the device is exposed to aqueous media—especially under cell culture conditions. For PDMS-based devices, leaching of uncrosslinked oligomers is specifically discussed as a significant problem in aqueous cell culture and tissue-on-a-chip environments.

keyword Release of uncrosslinked/low-MW polymer species from a polymer into surrounding fluid.

3) Transport and mass-transfer behavior (gas permeability, evaporation, diffusion)

Many BioMEMS experiments depend on oxygen and carbon dioxide transport. PDMS is known for high gas permeability, which can be an advantage for maintaining cell microenvironment oxygenation in microfluidic devices. However, high permeability and porous nature can also increase sensitivity to ambient gas concentration and humidity, potentially affecting medium pH and osmolarity.

keyword Ability of a polymer matrix to allow gases to diffuse through it (key for cell microenvironments).

4) Surface wettability and non-specific adsorption (biofouling)

Many biological media interactions are governed by the polymer surface:

• Hydrophobic surfaces can promote non-specific protein adsorption.
• Protein adsorption can alter cell adhesion, signaling, and assay readouts. PDMS is naturally hydrophobic (commonly reported water contact angle near $\sim 108^\circ$), which often limits some biological applications where aqueous solutions are required.

keyword A proxy for surface wettability; higher values indicate more hydrophobic surfaces. keyword Unwanted biological material adsorption (e.g., proteins) on device surfaces.

5) Optical and fabrication compatibility

Optical transparency supports microscopy-based readouts; rapid prototyping via soft lithography supports iteration cycles needed in BioMEMS research. PDMS’s optical transparency and simple fabrication via replica molding/soft lithography are repeatedly highlighted in biomedical engineering reviews.

PDMS (Polydimethylsiloxane): why it dominates BioMEMS

Polydimethylsiloxane (PDMS) is an elastomeric silicone polymer commonly used for microfluidics and BioMEMS due to a combination of properties:

• Biocompatibility/physiological indifference (reported as a reason for widespread use)
• Chemical stability
• Gas permeability
• Optical transparency
• Good mechanical properties
• Simple fabrication by replica molding/soft lithography

These attributes make PDMS a foundational material for many microfluidic components and biomedical microdevices.

PDMS structural/processing background (why curing matters)

PDMS devices are typically formed from a base polymer blended with a curing agent, crosslinked to form an elastomer network. Because the degree of crosslinking strongly affects the presence of residual polymer chains, incomplete curing increases the risk of oligomer leaching into aqueous systems.

PDMS properties relevant to BioMEMS: advantages and trade-offs

Advantage: gas permeability for cell microenvironments

High gas permeability is widely cited as a favorable property for PDMS microfluidic use in biology. In addition, PDMS’s porous nature and permeability link directly to oxygen/CO$_2$ exchange, which can be beneficial for cell culture microenvironments, provided the ambient conditions are controlled.

Trade-off: hydrophobic surface and biofouling risk

PDMS’s hydrophobicity can lead to undesired non-specific protein adsorption, which can affect analyte transport and detection sensitivity in microfluidic assays. This often motivates surface modification strategies (e.g., plasma activation followed by bonding, or grafting/adsorbed hydrophilic coatings).

keyword Chemical/physical treatment to change polymer surface chemistry to improve biological performance.

Trade-off: leaching of uncrosslinked oligomers

In cell culture contexts, PDMS leaching is described as problematic: uncrosslinked polymer chains can diffuse out, potentially impacting cultured cells and complicating analyses.

How PDMS is processed for microfluidic/BioMEMS assembly: plasma bonding

A core fabrication step for PDMS BioMEMS is irreversibly bonding layers or bonding to other substrates. Oxygen plasma treatment is commonly used to oxidize the PDMS surface (increasing hydrophilicity) and enable strong covalent bonding—critical for sealing microchannels.

The literature specifically notes that PDMS is frequently used for multilayer bio-microfluidic devices and that bonding is essential; oxygen plasma treatment is a widely used surface modification/bonding approach.

[mermaid] graph TD A["Cast & cure PDMS"] --> B["O2 plasma oxidizes surface"]; B["Surface becomes hydrophilic"] --> C["Press layers together quickly"]; C["Irreversible covalent bonding"] --> D["Assembled BioMEMS / microfluidic chip"];

Applications of PDMS in BioMEMS (what it enables)

PDMS is widely used across microfluidics-driven biomedical platforms, including:

• Microfluidic cell culture and tissue-on-a-chip concepts, where multilayer chips and controlled environments are needed.
• Organ-on-a-chip (OoC) biosensor platforms, leveraging PDMS’s biocompatibility, optical transparency, and microfluidic integration versatility, while acknowledging hydrophobicity and small-molecule absorption challenges.
• Integrated microfluidic biosensors, where PDMS-based chips are used as device substrates and microfluidic frameworks for biological sensing and assays (including microfluidic stimulation and diagnostic workflows).

keyword Microfluidic device that models organ-level physiology using living cells. keyword Culturing cells in microchannels for controlled microenvironments.

Practical guidance for using PDMS biocompatibly in BioMEMS

1) Manage curing completeness to reduce leaching

Because incomplete curing can leave uncrosslinked chains that later leach into aqueous media, minimizing uncured/uncrosslinked content is emphasized for sensitive cell culture applications.

2) Control surface wettability and fouling

Given PDMS hydrophobicity and its tendency toward non-specific protein adsorption, consider:

• plasma activation for bonding (and sometimes short-term wettability),
• additional surface functionalization for longer-term aqueous compatibility,
• and workflow timing to reduce hydrophobic recovery.2

3) Account for gas transport side effects

Because PDMS’s porous nature supports gas exchange, microenvironment pH/osmolarity can drift if ambient gas and humidity are not controlled.